Reaction equation
C(C=C(C#N)C([O-])=O)CCC.[CH3:12][C@@H:13]1[O:18][C@@H:17]([O:19][C@@H:20]2[C:25]3=[C:26]([OH:43])[C:27]4[C:39](=[O:40])[C:38]5[C:33](=[CH:34][CH:35]=[CH:36][C:37]=5[O:41][CH3:42])[C:31](=[O:32])[C:28]=4[C:29]([OH:30])=[C:24]3[CH2:23][C@@:22]([OH:48])([C:44]([CH2:46][OH:47])=[O:45])[CH2:21]2)[CH2:16][C@H:15]([NH2:49])[C@@H:14]1[OH:50].Cl>Cl.O>[CH3:12][C@@H:13]1[O:18][C@@H:17]([O:19][C@@H:20]2[C:25]3=[C:26]([OH:43])[C:27]4[C:39](=[O:40])[C:38]5[C:33](=[CH:34][CH:35]=[CH:36][C:37]=5[O:41][CH3:42])[C:31](=[O:32])[C:28]=4[C:29]([OH:30])=[C:24]3[CH2:23][C@@:22]([OH:48])([C:44]([CH2:46][OH:47])=[O:45])[CH2:21]2)[CH2:16][C@H:15]([NH2:49])[C@@H:14]1[OH:50]Participants
5
Reactant 2
Product 1
Reagents, catalysts & solvents 2
Procedure
100 μl of n-butylcyanoacrylate monomer was added to 1% dextran solution in 8 mL of 0.01 M HCl under constant stirring at 600 rpm. Doxorubicin hydrochloride powder 50 mg was dissolved in 2 mL of distilled water and after 40 minutes the solution was added to the reaction flask. After 4 hours the pH of the nanoparticle suspension was adjusted at 7 and filtered through 0.8 μm membrane filter (Nuclepore Track-Etch membrane, Whatman, USA). The doxorubicin-loaded nanoparticle suspension was kept in a refrigerator at 4° C.
Workup
- additionwas added to the reaction flask
- filtrationfiltered through 0.8 μm membrane
- filtrationfilter (Nuclepore Track-Etch membrane, Whatman, USA)
- customwas kept in a refrigerator at 4° C.
Sources & evidence
- ORD record
- ord-b591766626c745f0a9a57ca2344fd3c7
- Source dataset
- uspto-grants-2011_05
- Patent number
- US07947308B2
Linked notes
Loading…